🔗 Permalink

Inventor profile of:

John Docherty

City:

Port Perry

Country:

Canada

Published Applications:

34

Last publication date:

2026-02-26

Top Assignees for applications by John Docherty

The entities that hold a legal rights for patent applications filed by inventor Docherty John:

POVIVA CORP. 15 Carson City, NV United States
POVIVA CORP 1 Kelowna, Canada

Recent patent applications by Docherty John

John Docherty from Port Perry, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26

US20260053894A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#2 | 2026-02-12

US20260041737A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#3 | 2025-12-25

US20250387416A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#4 | 2025-11-20

US20250352623A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#5 | 2025-06-05

US20250177489A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#6 | 2025-06-05

US20250177488A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#7 | 2025-06-05

US20250177314A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#8 | 2025-05-22

US20250161333A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING EPILEPSY

#9 | 2025-01-30

US20250032518A1

Human necessities

Compositions and methods for treating epilepsy

#10 | 2025-01-30

US20250032517A1

Human necessities

Compositions and methods for treating epilepsy

#11 | 2025-01-30

US20250032516A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING EPILEPSY

#12 | 2024-07-11

US20240226033A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING HYPERTENSION

#13 | 2024-07-02

US18225244

Human necessities

Compositions and methods for treating epilepsy

#14 | 2024-05-21

US18225234

Human necessities

Compositions and methods for treating epilepsy

#15 | 2024-04-02

US18225252

Human necessities

Compositions and methods for treating epilepsy

#16 | 2024-03-19

US18225227

Human necessities

Compositions and methods for treating epilepsy

#17 | 2024-01-11

US20240009141A1

Human necessities

Compositions and methods for treating hypertension

#18 | 2024-01-11

US20240009140A1

Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERTENSION

#19 | 2023-09-28

US20230301341A1

Human necessities

COMPOSITIONS AND METHODS FOR SUBLINGUAL DELIVERY OF NICOTINE

#20 | 2023-07-18

US17700628

Human necessities

Compositions and methods for sublingual delivery of nicotine

#21 | 2023-06-06

US17857985

Human necessities

Compositions and methods for treating hypertension

#22 | 2023-06-06

US17857958

Human necessities

Pharmaceutical compositions and methods for treating hypertension

#23 | 2023-03-30

US20230094827A1

Human necessities

NANOEMULSION COMPOSITIONS COMPRISING BIOLOGICALLY ACTIVE INGREDIENTS

#24 | 2022-05-26

US20220160731A1

Human necessities

COMPOSITIONS COMPRISING BIOLOGICALLY ACTIVE AGENTS AND BILE SALTS

#25 | 2022-02-24

US20220054495A1

Human necessities

Compositions and methods for enhanced delivery of antiviral agents

#26 | 2021-10-28

US20210330683A1

Human necessities

COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS

#27 | 2021-09-23

US20210289832A1

Human necessities

LIPOPHILIC ACTIVE AGENT INFUSED TOBACCO LEAVES AND/OR TOBACCO MATERIALS AND METHODS OF USE THEREOF

#28 | 2021-07-15

US20210213091A1

Human necessities

LIPOPHILIC ACTIVE AGENT INFUSED TOBACCO LEAVES AND/OR TOBACCO MATERIALS AND METHODS OF USE THEREOF

#29 | 2021-06-17

US20210177978A1

Human necessities

METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS

#30 | 2021-05-20

US20210145841A1

Human necessities

ENHANCEMENT OF DELIVERY OF LIPOPHILIC ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS

#31 | 2021-05-20

US20210145818A1

Human necessities

COMPOSITIONS INFUSED WITH NICOTINE COMPOUNDS AND METHODS OF USE THEREOF

#32 | 2021-05-20

US20210145036A1

Human necessities

LIPOPHILIC ACTIVE AGENT INFUSED COMPOSITIONS WITH REDUCED FOOD EFFECT

#33 | 2021-02-18

US20210045998A1

Human necessities

TRANSDERMAL AND/OR DERMAL DELIVERY OF LIPOPHILIC ACTIVE AGENTS

#34 | 2020-10-15

US20200323773A1

Human necessities

FOOD AND BEVERAGE COMPOSITIONS COMPRISING PDE5 INHIBITORS

InventorID:

2877003 ⎘